Top Links

Articles Related to papillomavirus

Quadrivalent Human Papillomavirus Vaccine and the Young Ovary: Review of Safety Research Following Two Case Series of Premature Ovarian Insufficiency

The quadrivalent virus-like particle vaccine against human papillomavirus (QHPV) is a population vaccine targeting peri-pubertal girls and boys. Focus on evaluation of adolescent ovarian safety arises from cases in primary care and published case series describing the development of menstrual dysfunction and idiopathic premature ovarian insufficiency (POI) following QHPV vaccination. A structured review of QHPV vaccine safety studies was performed to answer the question ‘has the ongoing ovarian safety of this vaccine in adolescents been assessed?’ The design, size, and process of pre-licensing safety trials in relation to their capacity to assess ovarian function were reviewed.
View complete article: PDF  |  Full-text

Diagnostic Approaches towards Camelpox Disease

Camelpox is routinely diagnosed based on clinical signs, pathological findings and cellular and molecular assays.
View complete article: PDF  |  Full-text

m6a RNA Methylation: The Implications for Health and Disease

The recent resurgence of interest in m6A has been spurred by some intriguing findings detailing the effects and dynamics of this epigenetic modification. The m6A modification is a highly reactive and fluid modification which can respond rapidly to a broad variety of stimuli, and translate these signals into cellular activity. The little information that has been established on its functional capacity has opened up many new avenues of research and has tremendous implications for several fields of study.
View complete article: PDF  |  Full-text


Editorial Board Members Related to papillomavirus

Angel Simeonov Galabov

Professor
Department of Virology
The Stephan Angeloff Institute of Microbiology
Bulgaria
Submit Manuscript